immunogenicity of ghk-cu peptide compared to other peptides The tri-peptide complex ameliorates lipopolysaccharide-induced acute lung injury in mice AHK-Cu Peptide: the complete guide – GHK-Cu ✨ A naturally occurring

Key Planning Considerations for Compounders, Telehealth Platforms, Med Spas and Other Stakeholders Below, we outline some key considerations that stakeholders should consider as they prepare for potential policy changes regarding the peptides discussed at the PCAC meeting

Factors that influence outcomes include genetics, age, baseline skin quality, and compliance with the peptide protocol

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

Imaging the impact of cortical microcirculation on synaptic structure and sensory-evoked hemodynamic responses in vivo